Third annual Destination Startup® event expands across the Mountain-West, connecting top research-based startups with investors

Third annual Destination Startup® event expands across the Mountain-West, connecting top research-based startups with investors

Feb. 16, 2021

From February 16-18, 2021, Venture Partners will host the biggest Destination Startup® yet, showcasing 25 startups from 10 different universities across six states in the Rocky Mountain region—not just Colorado—and drawing investors from around the world.

Faculty innovators recognized by National Academy of Inventors

Faculty innovators recognized by National Academy of Inventors

Feb. 10, 2021

The National Academy of Inventors (NAI) has announced that 񱦵 researchers Mark Rentschler, Greg Rieker and Tin Tin Su have been designated as NAI Senior Members in recognition of their impact on society through extraordinary innovation.

Third annual Destination Startup event goes regional, connecting top research-based startups with investors

Third annual Destination Startup event goes regional, connecting top research-based startups with investors

Jan. 19, 2021

From February 16-18, 2021, Venture Partners will host the biggest Destination Startup® yet, showcasing 26 startups from 10 different universities across six states in the Rocky Mountain region—not just Colorado—and drawing investors from around the world.

Lab Venture Challenge awards record-breaking $1.35 million to promising 񱦵 ventures

Lab Venture Challenge awards record-breaking $1.35 million to promising 񱦵 ventures

Dec. 15, 2020

Judges from the local entrepreneurial ecosystem awarded a record total of 12 grants—up to $125,000 each—for the top physical science, engineering and bioscience innovations demonstrating high commercial potential, a clear path to a compelling market and strong scientific support.

Lab Venture Challenge showcase for innovations with high commercial potential (Nov 18 & 19)

14 researchers to pitch their innovations for funding at Lab Venture Challenge (Nov. 18 & 19)

Nov. 17, 2020

Through the Lab Venture Challenge, Venture Partners at 񱦵 funds the university's top innovations addressing a commercial need, with a clear path to a compelling market and strong scientific support. This showcase is a can't-miss event to see breakthrough innovations.

Bristol Myers Squibb acquires MyoKardia, co-founded by 񱦵 faculty, for $13.1 billion in cash

Bristol Myers Squibb acquires MyoKardia, co-founded by 񱦵 faculty, for $13.1 billion in cash

Nov. 17, 2020

MyoKardia, a clinical-stage biopharmaceutical company discovering and developing targeted therapies for the treatment of serious cardiovascular diseases, was co-founded by Leslie Leinwand, Distinguished Professor of Molecular, Cellular, and Developmental Biology at 񱦵's BioFrontiers Institute.

PhET founder and Nobel laureate Carl Wieman awarded $4M Yidan Prize for Education Research

PhET founder and Nobel laureate Carl Wieman awarded $4M Yidan Prize for Education Research

Oct. 20, 2020

In September, the Yidan Prize Foundation awarded Carl Wieman the prestigious Yidan Prize in Education Research for his “contribution in developing new techniques and tools in STEM education.” Wieman will use prize and project money to support 񱦵’s award-winning PhET Interactive Simulations.

Why developing a successful COVID-19 vaccine is only half the battle

Why developing a successful COVID-19 vaccine is only half the battle

June 23, 2020

Step 1: Create a vaccine for COVID-19. Step 2: Distribute it across the world. This second step may be even more challenging than the first, which is why 񱦵 researchers and spinoff VitriVax are focused on finding a way to get vaccines to 7.8 billion people.

񱦵 spinout Artimus Robotics wins $225,000 NSF SBIR grant

񱦵 spinout Artimus Robotics wins $225,000 NSF SBIR grant

June 16, 2020

The robotics spinout company of 񱦵’s Paul M. Rady Department of Mechanical Engineering, will use the award to further their research into the unique electromechanical failure mechanism in HASEL actuators, a new class of smart, soft, high-speed robotic hardware.

COVID-19 innovations available for licensing and partnerships

COVID-19 innovations available for licensing and partnerships

May 19, 2020

Venture Partners at 񱦵 is identifying new innovations that address problems related to the COVID-19 pandemic. To ensure that COVID-19 innovations are rapidly brought to those who need them most, Venture Partners will be adopting an “Open Access” licensing strategy.

Pages